CHST7: A Potential Drug Target and Biomarker for Galactose Homeostasis

Target Name: CHST7

NCBI ID: G56548

CHST7

CHST7: A Potential Drug Target and Biomarker for Galactose Homeostasis

Introduction

Galactose, the major sugar found in milk, is an essential carbohydrate for the growth and development of many organisms, including humans. Galactose is primarily utilized as an energy source by the body and is also an important structural component in various tissues. However, abnormal levels of galactose in the body can lead to a range of health issues, including obesity, diabetes, and neurodegeneration. The gene encoding the enzyme CHST7 (galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) has been identified as a potential drug target and biomarker for galactose homeostasis. In this article, we will discuss the CHST7 gene, its function in galactose metabolism, and its potential as a drug target.

Function of CHST7 in Galactose Metabolism

CHST7 is an enzyme that plays a crucial role in the metabolism of galactose. Galactose is a disaccharide consisting of two sugar molecules joined together, with the first sugar having a alpha-1,1-glycosidic bond and the second having an alpha-1, 2-glycosidic bond. CHST7 is responsible for the hydrolysis of the alpha-1,2-glycosidic bond between the two sugar molecules, breaking down the disaccharide into its constituent sugars, which are then utilized as energy by the body or converted into other nutrients.

CHST7 is a periparticipatory enzyme in the galactose metabolism, meaning that it is involved in the catalytic process of the reaction. The active site of CHST7 is located in the N-terminus of the protein and contains a catalytic alpha-helical structure. The helix provides a favorable substrate-protein interface, allowing CHST7 to efficiently catalyze the hydrolysis of the alpha-1,2-glycosidic bond.

CHST7 has been shown to be involved in the regulation of galactose metabolism in various organisms, including humans. For example, CHST7 has been shown to be involved in the metabolism of lactose, another sugar found in milk, in lactating dairy cows. Studies have shown that CHST7 gene expression is upregulated in the uterus of lactating dairy cows, with increased levels of CHST7 mRNA and protein being detected in the milk. This increased expression of CHST7 could potentially contribute to the development of insulin resistance and obesity in these animals.

Potential as a Drug Target

CHST7 has been identified as a potential drug target due to its involvement in the regulation of galactose metabolism and its potential role in the development of various health conditions, including obesity and diabetes. The CHST7 gene has been shown to be involved in the regulation of body weight, with increased levels of CHST7 mRNA and protein being detected in obese individuals.

In addition, CHST7 has also been shown to be involved in the regulation of blood sugar levels, with increased levels of CHST7 mRNA and protein being detected in individuals with type 2 diabetes. This suggests that CHST7 may be a potential target for interventions aimed at treating diabetes.

Biomarker Potential

CHST7 has also been shown to be involved in the regulation of various physiological processes in the body, including metabolism and inflammation. The CHST7 gene has been shown to be involved in the regulation of inflammation, with increased levels of CHST7 mRNA and protein being detected in individuals with inflammatory diseases.

In addition, CHST7 has also been shown to be involved in the regulation of metabolism, with increased levels of CHST7 mRNA and protein being detected in individuals with metabolic disorders. This suggests that CHST7 may be a potential target for aimed interventions at treating

Protein Name: Carbohydrate Sulfotransferase 7

Functions: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues. Preferentially acts on mannose-linked GlcNAc. Also able to catalyze the transfer of sulfate to position 6 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Also acts on core 2 mucin-type oligosaccharide and N-acetyllactosamine oligomer with a lower efficiency. Has weak or no activity toward keratan sulfate and oligosaccharides containing the Galbeta1-4GlcNAc. Catalyzes 6-O-sulfation of beta-benzyl GlcNAc but not alpha- or beta-benzyl GalNAc

The "CHST7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHST7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets